Advances in Urology

Advances in Urology / 2016 / Article

Research Article | Open Access

Volume 2016 |Article ID 1015796 | 5 pages | https://doi.org/10.1155/2016/1015796

Severity of Lower Urinary Tract Symptoms among Middle Aged and Elderly Nigerian Men: Impact on Quality of Life

Academic Editor: Matthew Rutman
Received31 Mar 2016
Accepted31 May 2016
Published19 Jun 2016

Abstract

Objectives. To compare the severity of LUTS among middle aged and elderly Nigerian men and determine the influence of LUTS severity on QoL. Methods. This cross-sectional study was conducted among new patients presenting with LUTS attending Urology clinic between 2011 and 2015. Assessment of symptoms was based on IPSS and bother score completed by the eligible subjects on the same day of their clinic visits. Results. Four hundred patients were studied comprising 229 middle aged and 171 elderly men. Interquartile range (IQR) of IPSS scores for men <65 years and those ≥65 years was 14.0 (16.0) and 19 (15.0), respectively (). Mild LUTS was significantly associated with best, good, and poor quality of life while moderate LUTS was associated with poor QoL. Severe LUTS was significantly associated with all the categories of QoL (Best-Worst). Among the cohort of subjects with poor QoL, elderly patients had a significantly higher median IPSS score (). Conclusions. There is no level of severity of LUTS in which patients’ QoL is not impaired although mild symptomatology may be associated with better QoL and severe symptomatology with poor QoL. Careful attention to QoL may help identify patients who require early and prompt treatment irrespective of the IPSS.

1. Introduction

Olmsted County study, one of the largest longitudinal studies conducted in America, investigated age as one of many sociodemographic characteristics that may predict the incidence of LUTS/BPH. Also, age was reported to be one of the most reliable risk factors for the progression of LUTS/BPH. Its influence is greater than those of other sociodemographic characteristics [1].

Aging as a process has been discovered to be associated with the development of various, sometimes distressing, symptoms of different organ systems in the body including the genitourinary tract [2].

Besides, European and Korean EPIC studies have estimated that about 2/3rd of LUTS is present in the middle aged men whereas other researchers reported that the conditions leading to LUTS are among the most prevalent diseases of the elderly, with serious impairment of quality of life [QoL] [1, 315].

However, as men age, there is an increasing prevalence of Lower Urinary Tract Symptoms (LUTS) but no clear difference in the impact of LUTS on the QoL between the middle aged and the elderly men [16].

Therefore, there is the need to differentiate between the effects of severity of LUTS on the quality of life of middle aged and the elderly men. Comparison of impact of LUTS in these men is important to improve the management of LUTS in men, some of whom are still in the working class and the bread winners for their families.

The objective of this study was to compare the severity of LUTS among middle aged and elderly Nigerian men attending the Urology clinic at Ekiti State University Teaching Hospital, South Western Nigeria. We also aimed to determine the influence of LUTS severity on the QoL of these men.

2. Methods

2.1. Settings

This was a comparative cross-sectional study carried out on all new patients who presented to the Urology clinic of Ekiti State University Teaching Hospital, Ado-Ekiti, South Western Nigerian from July 1, 2011, to June 30, 2015.

2.2. Selection Criteria and Data Collection

The inclusion criteria were male sex; 40 years aged and above; voluntary participation; and understanding and signing the consent form. The exclusion criteria were previous open prostatectomy; acute diseases such as sepsis syndrome, cardiovascular events, and trauma; surgeries or hospitalizations during the preceding month; and uncompensated chronic diseases.

A questionnaire containing sociodemographics and concurrent medical conditions including history of alcohol ingestion and 8-item International Prostate Symptoms Score (IPSS) (English version was used because official national language in Nigeria is English) was completed by the eligible subjects on the same day of their clinic visits. The IPSS is a reliable and widely used instrument since 1991, and it is based on the answers to seven questions concerning urinary symptoms and one question concerning quality of life [17]. Each question concerning urinary symptoms allows the patient to choose one out of six answers indicating increasing severity of the particular symptom. The answers are assigned points from 0 to 5. The total score ranges from 0 to 35 (asymptomatic to very symptomatic). The questions refer to the following urinary symptoms: (i) incomplete emptying, (ii) frequency, (iii) intermittency, (iv) urgency, (v) weak stream, (vi) straining, and (vii) nocturia. Question  8 measures patient’s perceived quality of life (QoL) which comprises seven answers from 0 to 6. The quality of life or level of satisfaction of LUTS of patients was represented by seven grades: “no problem” (0 point  =  very satisfied), “I’m all right” (1 point), “somewhat satisfied” (2 points), “half satisfied, half dissatisfied” (3 points), “somewhat dissatisfied” (4 points), “distressed” (5 points), and “I can’t stand it” (6 points  = very dissatisfied).

Self-administration of questionnaires was preferred, but face-to-face interviews were conducted whenever the participants presented with visual deficits, illiteracy, or semi-illiteracy that would preclude them from proper completion of the questionnaire. Thirteen (13) participants had their questionnaire interviewer administered. Trained medical staff conducted the interviews in private rooms, which lasted an average of 30 minutes.

2.3. Ethical Issues

The study was conducted in accordance with Declaration of Helsinki (as revised in Edinburgh 2000). Written informed consent was obtained from all participants before participation in the study.

Ethical approval was obtained from Ethical Research Committee of the Ekiti State University Teaching Hospital, Ado-Ekiti, Nigeria.

2.4. Statistical Analysis

For statistical analysis, the subject’s demographic and clinical variables were summarized and presented as frequencies and percentages for categorical variables while numerical data were summarized as means and standard deviation when normally distributed and median with interquartile range (IQR) when skewed. IPSS was categorized into mild (0–7), moderate (8–19) and severe symptoms (20–35) while quality of life (QoL) defined by bother score was categorized as best for BS = 0-1; good for BS = 2-3; poor for BS = 4-5; and worst for BS = 6.

Patients demographic and clinical data were summarized and presented as frequencies and percentages while the chi-squared test was used to test differences between the middle aged (<65 years) and elderly men (≥65 years). Skewed continuous variables were summarized as median (interquartile range) while Mann-Whitney nonparametric test was used to test the differences in the median values between middle aged and elderly subjects. Chi-squared test was used to analyse the difference between quality of life categories (bother score) and severity of LUTS (defined by IPSS). To detect the significant group, the chi-squared test was followed by a multiple pairwise comparison test with adjustment of the values. All statistical analyses were performed using SPSS version 20.0 (SPSS, Chicago, Illinois). A value < 0.05 was considered to be statistically significant while adjusted value of <0.0042 was considered significant for the post hoc pairwise comparison.

3. Results

Table 1 showed that while elderly men were either married or widowers or single or divorced men could be found among the middle aged. This finding was statistically significant. In addition, majority of the elderly men were retired. While majority of the middle aged cohort were overweight, normal weight and obese men were more common among the elderly. This was also significant. Among the comorbidities studied, systemic hypertension and diabetes mellitus were more prevalent in the elderly, while alcohol consumption was prevalent in the middle aged men. Table 2 showed that the severity of LUTS was significantly worse among subjects of 65 years and above ().


VariablesAge < 65 years; 229 (%)Age ≥ 65 years; 171 (%)Test statistics value

Marital status<0.001
 Single23 (10)0 (0)35.36
 Married193 (84.3)166 (97.1)
 Divorced13 (5.7)0 (0)
 Widower0 (0)5 (2.9)
Occupation77.62<0.001
 Public servant106 (46.3)19 (11.1)
 Business31 (13.5)45 (26.3)
 Retired39 (17.0)79 (46.2)
 Others53 (23.1)28 (16.4)
BMI
 Underweight0 (0)1 (0.6)11.210.011
 Normal67 (29.3)71 (41.5)
 Overweight126 (55.0)67 (39.2)
 Obese36 (15.7)32 (18.7)
Comorbidities
 Hypertension120 (52.4)115 (67.3)8.910.003
 Diabetes mellitus18 (7.9)20 (11.7)1.670.196
 Alcohol91 (39.7)36 (21.1)11.050.001
Ultrasound findings
 Normal size52 (22.7)2 (1.2)11.950.003
 Enlarged and benign161 (70.3)160 (93.6)
 Suspected cancer16 (7.0)9 (5.3)
DRE18.50<0.001
 Normal sized prostate35 (15.3)9 (5.3)
 Enlarged and benign178 (77.7)161 (94.2)
 Suspicious lesion16 (7.0)1 (0.6)
Diagnosis5.460.141
 BPH181 (79.0)141 (82.5)
CaP23 (10.0)22 (12.9)
 Urethral stricture6 (2.6)2 (1.2)
 Others for example OAB19 (8.3)6 (3.5)

CaP = cancer of the prostate; OAB = overactive bladder.

VariablesAge < 65 yearsAge ≥ 65 yearsMann-Whitney test value
Median (IQR)Median (IQR)

IPSS14.0 (16.0)19.0 (15.0)15435.0<0.001
Voiding symptoms7.0 (12.0)9.0 (10.0)16041.00.002
Storage symptoms7.0 (7.0)9.0 (5.0)15804.50.001

Table 3 showed the quality of life of patients with LUTS in relation to the severity of the symptoms where the IPSS score was categorized. There was a statistically significant relationship between the severity of LUTS and the QoL of the subjects.


IPSS severityBother scoreChi-squared test value
Best QoLGood QoLPoor QoLWorst QoL
(%) (%) (%) (%)

Mildly symptomatic26 (68.4)42 (55.3)12 (4.3)0 (0)175.75<0.001
Moderately symptomatic10 (26.3)21 (27.6)136 (49.3)0 (0)
Severely symptomatic2 (5.3)13 (17.1)128 (46.4)10 (100)

Total36 (100)76 (100)276 (100)10 (100)

Table 4 shows the results of post hoc multiple pairwise comparisons of the categories of the contingency Table 3 after the chi-squared test has rejected the null hypothesis of equality of proportions of subjects across the cells. The table showed the pairwise proportions among the multiple cross-classifications that led to the statistical significance observed in Table 3 after adjusting the value to 0.0042. Mild symptomatic was significantly associated with best, good, and poor quality of life while moderate symptomatic was associated with poor QoL. Severe symptomatic was significantly associated with the entire categories of QoL (Best-Worst).


Pair comparedChi-squared test value

Mildly symptomatic versus best QoL60.84<0.001
Mildly symptomatic versus good QoL72.25<0.001
Mildly symptomatic versus poor QoL136.89<0.001
Mildly symptomatic versus worst QoL2.560.109
Moderately symptomatic versus best QoL4.000.046
Moderately symptomatic versus good QoL7.840.005
Moderately symptomatic versus poor QoL21.16<0.001
Moderately symptomatic versus worst QoL7.290.007
Severely symptomatic versus best QoL19.36<0.001
Severely symptomatic versus good QoL17.64<0.001
Severely symptomatic versus poor QoL25.00<0.001
Severely symptomatic versus worst QoL16.81<0.001

Adjusted value = 0.0042.
statistically significant.

Figure 1 showed the IPSS scores among the subjects with different perceived QoL according to the age group. Among the cohort with best quality of life, the elderly patients had a statistically significant median IPSS score (). No statistical difference exists between the median IPSS scores of the cohort who had good QoL (). Among the cohort of subjects with poor QoL, elderly patients had a statistically significantly higher median IPSS score ().

4. Discussion

We sought to compare the severity of symptoms on the QoL of middle aged and elderly Nigerian men. This result showed that QoL was affected by any category of symptoms (mild to severe) across the age. It was demonstrated in this study that even mild symptomatology of IPSS could be associated with poor quality of life whereas some severe symptomatology was associated with good QoL . Therefore patients’ health seeking behaviour might have been influenced by their QoL rather than the severity of the IPSS score. This finding is in agreement with the report of Finkelstein et al. that discovered that an individual’s perceived impact on health-related quality of life might be a determinant for patients to seek medical advice [18].

In addition, the study also showed that severity of IPSS increases with age (). This is similar to the findings of Engström et al. that reported that severity of symptoms increases with age [19].

More importantly, among the cohort with best quality of life, the elderly patients had a statistically significant higher median IPSS score (). This might be due to high prevalence of hypertension in the elderly which could increase IPSS coupled with higher prevalence of alcohol consumption in the middle aged which might cause lower IPSS in them. However, a longitudinal study on the volume of alcohol consumption in this environment is necessary to corroborate this assertion. This is in line with Suh et al., Lu, and Mo that reported a similar protective effect of light-moderate alcohol consumption on IPSS [20, 21].

Furthermore, this study showed that elderly men had higher frequency of poor QoL . This is similar to the findings of Welch et al. that men with moderate and severe LUTS identified in a large US cohort had a poorer health status in several important quality of life dimensions [14]. It is important that these elderly men are adequately assessed for appropriate therapy. Surgical treatments have been strongly favoured for moderate to severe symptomatic patients and watchful waiting or conservative measures indicated for patients with mild complaints [2224].

Recognition of significant deterioration of QoL among mild, moderate, and severe LUTS patients is an evidence for the need of treatment (as opposed to watchful and conservative approaches) and justification for early treatment irrespective of IPSS score. This is in consonance with Finkelstein et al. that noted that the IPSS quality of life question had a larger effect size than all the other measures suggesting that this single-item measure may have high sensitivity to differentiate subgroups [18].

5. Conclusion

From the foregoing, it might be better to use the QoL as determinant of the choice of treatment rather than the IPSS scores alone for prompt treatment of LUTS and improved clinical outcome.

6. Limitation of the Study

However, criticisms have been made regarding the poor standardization of QoL scales and the frequent inappropriate use of the term QoL. The use of a one-item scale to assess general QoL (the IPSS-QoL question, called “bother score”) and the misinterpretation of QoL as synonymous to symptom-control or perceived general health or functional status are the most frequent reasons for such criticisms. Besides, because this study was hospital-based, it may not be a true random sample of men with LUTS in the general population. It is difficult to eliminate selection bias.

Furthermore, we did not evaluate for depressive symptomatology and other psychosocial contributors to QoL perception. However, the measure of QoL in this study is a disease specific instrument with psychometric properties well fitted to measure QoL as it relates to urinary symptoms.

Competing Interests

The authors have no conflict of interests.

References

  1. J. T. Wei, E. Calhoun, and S. J. Jacobsen, “Urologic diseases in America project: benign prostatic hyperplasia,” Journal of Urology, vol. 179, no. 5, pp. S75–S80, 2008. View at: Publisher Site | Google Scholar
  2. E. Plas and L. K. Daha, “Hormonal replacement therapy for the aging bladder,” in The Aging Bladder Day, E. Plas, Ed., pp. 137–147, Springer, Wien, Austria, 2004. View at: Google Scholar
  3. D. E. Irwin, I. Milsom, S. Hunskaar et al., “Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study,” European Urology, vol. 50, no. 6, pp. 1306–1315, 2006. View at: Publisher Site | Google Scholar
  4. Y.-S. Lee, K.-S. Lee, J. H. Jung et al., “Prevalence of overactive bladder, urinary incontinence, and lower urinary tract symptoms: results of Korean EPIC study,” World Journal of Urology, vol. 29, no. 2, pp. 185–190, 2011. View at: Publisher Site | Google Scholar
  5. J. M. Fitzpatrick, “The natural history of benign prostatic hyperplasia,” BJU International, vol. 97, no. 2, pp. 3–6, 2006. View at: Publisher Site | Google Scholar
  6. A. L. Burnett and A. J. Wein, “Benign prostatic hyperplasia in primary care: what you need to know,” Journal of Urology, vol. 175, no. 3, pp. S19–S24, 2006. View at: Publisher Site | Google Scholar
  7. J. J. Medina, R. O. Parra, and R. G. Moore, “Benign prostatic hyperplasia (the aging prostate),” Medical Clinics of North America, vol. 83, no. 5, pp. 1213–1229, 1999. View at: Publisher Site | Google Scholar
  8. C. J. Girman, S. J. Jacobsen, T. Tsukamoto et al., “Health-related quality of life associated with lower urinary tract symptoms in four countries,” Urology, vol. 51, no. 3, pp. 428–436, 1998. View at: Publisher Site | Google Scholar
  9. P. Trueman, S. C. Hood, U. S. L. Nayak, and M. F. Mrazek, “Prevalence of lower urinary tract symptoms and self-reported diagnosed ‘benign prostatic hyperplasia’, and their effect on quality of life in a community-based survey of men in the UK,” BJU International, vol. 83, no. 4, pp. 410–415, 1999. View at: Publisher Site | Google Scholar
  10. A. Bertaccini, F. Vassallo, F. Martino et al., “Symptoms, bothersomeness and quality of life in patients with LUTS suggestive of BPH,” European Urology, vol. 40, no. 1, pp. 13–18, 2001. View at: Google Scholar
  11. A. S. Salinas-Sánchez, I. Hernández-Millán, J. G. Lorenzo-Romero, M. Segura-Martín, C. Fernández-Olano, and J. A. Virseda-Rodriguez, “Quality of life of patients on the waiting list for benign prostatic hyperplasia surgery,” Quality of Life Research, vol. 10, no. 6, pp. 543–553, 2001. View at: Publisher Site | Google Scholar
  12. K. F. Quek, C. S. Loh, W. Y. Low, and A. H. Razack, “Quality of life assessment before and after transurethral resection of the prostate in patients with lower urinary tract symptoms,” World Journal of Urology, vol. 19, no. 5, pp. 358–364, 2001. View at: Publisher Site | Google Scholar
  13. K. Yoshimura, Y. Arai, K. Ichioka, N. Terada, Y. Matsuta, and K. Okubo, “Symptom-specific quality of life in patients with benign prostatic hyperplasia,” International Journal of Urology, vol. 9, no. 9, pp. 485–490, 2002. View at: Publisher Site | Google Scholar
  14. G. Welch, K. Weinger, and M. J. Barry, “Quality-of-life impact of lower urinary tract symptom severity: results from the Health Professionals Follow-up Study,” Urology, vol. 59, no. 2, pp. 245–250, 2002. View at: Publisher Site | Google Scholar
  15. A. F. Bobé, A. M. E. Buil, B. A. I. Allué, G. A. Morro, E. M. Maxenchs, and B. M. Gens, “Benign prostate hyperplasia. Need to evaluate quality of life in the therapeutic process,” Atencion Primaria, vol. 38, no. 7, pp. 387–391, 2006. View at: Publisher Site | Google Scholar
  16. N. M. Resnick, “Urinary incontinence,” The Lancet, vol. 346, no. 8967, pp. 94–99, 1995. View at: Publisher Site | Google Scholar
  17. M. J. Barry, F. J. Fowler Jr., M. P. O'Leary, R. C. Bruskewitz, H. L. Holtgrewe, and W. K. Mebust, “Measuring disease-specific health status in men with benign prostatic hyperplasia. Measurement Committee of the American Urological Association,” Medical Care, vol. 33, no. 4, Article ID AS145, 1995. View at: Publisher Site | Google Scholar
  18. M. M. Finkelstein, J. Skelly, J. Kaczorowski, and G. Swanson, “Incontinence quality of life instrument in a survey of primary care physicians,” Journal of Family Practice, vol. 51, article 952, 2002. View at: Google Scholar
  19. G. Engström, L. Henningsohn, G. Steineck, and J. Leppert, “Self-assessed health, sadness and happiness in relation to the total burden of symptoms from the lower urinary tract,” BJU International, vol. 95, no. 6, pp. 810–815, 2005. View at: Publisher Site | Google Scholar
  20. B. Suh, D. W. Shin, S.-S. Hwang et al., “Alcohol is longitudinally associated with lower urinary tract symptoms partially via high-density lipoprotein,” Alcoholism: Clinical and Experimental Research, vol. 38, no. 11, pp. 2878–2883, 2014. View at: Publisher Site | Google Scholar
  21. Z. Lu and Z. Mo, “Association of alcohol consumption with lower urinary tract symptoms in a Chinese male population survey,” Translational Andrology and Urology, vol. 3, supplement 1, Article ID AB106, 2014. View at: Publisher Site | Google Scholar
  22. A. L. Burnett and A. J. Wein, “Benign prostatic hyperplasia in primary care: what you need to know,” The Journal of Urology, vol. 175, no. 3, pp. S19–S24, 2006. View at: Publisher Site | Google Scholar
  23. M. J. Barry, A. G. Mulley Jr., F. J. Fowler, and J. W. Wennberg, “Watchful waiting vs immediate transurethral resection for symptomatic prostatism. The importance of patient's preferences,” The Journal of the American Medical Association, vol. 259, no. 20, pp. 3010–3017, 1988. View at: Publisher Site | Google Scholar
  24. M. Oelke, A. Bachmann, A. Descazeaud et al., “EAU guidelines on male lower urinary tract symptoms (LUTS), including benign prostatic obstruction (BPO),” in Proceedings of the Male Lower Urinary Tract, pp. 123–144, 2012. View at: Google Scholar

Copyright © 2016 Patrick Temi Adegun et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

1213 Views | 343 Downloads | 2 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.